Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Filings indexed 339 across all filing types
Latest filing 2026-04-15 Annual Report
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories - Annual Report 2025 - Attachment: Inify Laboratories Annual Report 2025.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'Inify Laboratories Annual Report 2025'. It contains standard annual report sections such as 'CEO's comment', 'Highlights 2025', 'Operations', 'Corporate Governance', 'Financial statements', and 'Auditor's Report'. The content provides a comprehensive overview of the company's yearly performance, strategy, and financial outlook, fitting the definition of an Annual Report (10-K). FY 2025
2026-04-15 English
Inify Laboratories - Årsredovisning 2025
Report Publication Announcement Classification · 85% confidence The document is a brief press release (1,909 characters) announcing that the company’s Annual Report for the year ending 31 December 2025 is attached and available online. It does not contain the full annual report content itself. Under the “menu vs. meal” rule – short announcement of a report being published – this is a Report Publication Announcement.
2026-04-15 Swedish
Inify Laboratories - Annual Report 2025
Report Publication Announcement Classification · 92% confidence The document is a brief press release announcing the availability of Inify Laboratories’ Annual Report for the fiscal year ended December 31, 2025. It does not contain the full report content but states that the report is attached and available on the company’s website. Under the “menu vs meal” rule, this is a publication announcement of a report rather than the report itself. Accordingly, it should be classified as a Report Publication Announcement (RPA).
2026-04-15 English
Inify Laboratories - kallelse till årsstämma den 20 maj 2026 - Attachment: Inify_Laboratories_kallelse_bolagsstamma_2026_05_20.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is the official notice (“Kallelse till årsstämma”) convening the Annual General Meeting, with agenda, proposals, and proxy forms for shareholders. It is not the AGM materials or presentations themselves, but the meeting notice and proxy solicitation package. This fits the Proxy Solicitation & Information Statement category (Code: PSI).
2026-04-15 Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2026 - Attachment: Inify_Laboratories_AGM_invitation_May_20_2026.pdf
Proxy Solicitation & Information Statement Classification · 88% confidence The document is the formal notice to shareholders of Inify Laboratories’ Annual General Meeting, detailing the meeting date, agenda items, proposals (board elections, loss allocation, remuneration etc.), shareholder participation requirements, and including proxy and attendance forms. This is classic proxy solicitation and information material sent to shareholders ahead of a vote, fitting the Proxy Solicitation & Information Statement category (PSI). It is neither the AGM presentation (AGM-R) nor a report publication announcement (RPA), but rather the informational and voting request package for the meeting.
2026-04-15 English
Inify Laboratories - kallelse till årsstämma den 20 maj 2026
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a notice (“kallelse”) convening the Annual General Meeting on May 20, 2026, addressed to shareholders, including the agenda and information on registration and voting rights. This fits the definition of Proxy Solicitation & Information Statement (PSI): materials sent to shareholders to provide meeting information and request votes.
2026-04-15 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.